OpenVSafe by OpenVAERS
Search V-safe

3R4-27742-68067

3 vaccinations 2 coded responses 13 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
402 / KY
Registered
2021-11-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
Q3D-18098-58052 Child or adolescent in my care · Female · 2022-06-27
CVD-17941-96029 Child or adolescent in my care · Female · 2022-06-27

Timeline

  1. 2021-03-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-15
    Dose 2 — Pfizer-BioNTech
  3. 2021-11-04
    Registered in v-safe
  4. 2021-11-04
    Dose 3 — Pfizer-BioNTech
  5. 2021-11-05
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-11-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  7. 2021-11-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2021-11-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-11-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-11-13
    Health check-in — day 7, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  11. 2021-11-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  12. 2021-11-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-12-02
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-12-09
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-12-16
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-02-03
    Survey response — 3 months, dose 3
    MedDRA: Cough, Nasopharyngitis, Sinusitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cold with a cough and sinus infection
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-02-03
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  18. 2022-02-04
  19. 2022-05-05
    Survey response — 6 months, dose 3
    MedDRA: Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cold/sinus infection
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-05-05
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  21. 2022-05-06

Vaccinations

DoseDateManufacturerCo-administered
12021-03-05Pfizer-BioNTech No
22021-04-15Pfizer-BioNTech No
32021-11-04Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-02-03 Unsuccessful
2022-05-05 Unsuccessful

Free text

Release 11 — 3 months, dose 3

2022-02-03

Symptoms: Cold with a cough and sinus infection

Release 11 — 6 months, dose 3

2022-05-05

Symptoms: Cold/sinus infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDNasopharyngitis · · ✓
SDSinusitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release